Search results
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks via Yahoo Finance· 4 days agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week...
Simply Wall St. via Yahoo Finance· 4 days agoArguably, this is well and truly reflected in the strong share price gain of 39%(per year) over the...
NBC Securities Inc. Raises Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 7 hours agoThe fund owned 1,222 shares of the company’s stock after purchasing an additional 205 shares during the period. NBC Securities Inc.’s holdings in Moderna
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 4 days agoDespite these impressive numbers, a deeper look into the company's financials reveals a Loss Per Share of 15.67. This analysis aims to determine whether Moderna's
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 1 day agoCanaccord Genuity Group lifted their price objective on shares of Moderna from $91.00 to $106.00 and gave the company a hold rating in a report on Friday ...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Post-pandemic problems: These stocks are still down more than 50 percent from their Covid highs
Bankrate via Yahoo Finance· 2 days agoIts shares traded as low as $3.55 in December 2022. Covid high stock price: $376.83 Current stock ...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoModerna, we move to examine the company in more detail. This includes an assessment of its current market status and performance. Present Market Standing of Moderna ...
Jim Cramer: This Industrial Company Is ‘Absolutely Terrific’, Recommends Buying Modine Manufacturing...
Benzinga· 2 days agoOn May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna with an In-Line rating and announced a price target of $120. On May 13, ...
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick...
Benzinga· 7 days agoEditor’s note: This story has been updated to correct an error in the price action of Charter...